Obinutuzumab in Primary MN

Clinical trial NCT05050214 · COMPLETED

Trial details

NCT number: NCT05050214
Sponsor: Mario Negri Institute for Pharmacological Research
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Membranous Nephropathy

Start date: 2022-02-18
Primary completion: 2026-03-12
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.